Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms in a Randomized Controlled Trial (RCT)

NCT07316088 is registered in ClinicalTrials.gov with Oui Therapeutics, Inc. as lead sponsor.

NCT NCT07316088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07316088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms in a Randomized Controlled Trial (RCT)
Lead sponsor
Oui Therapeutics, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 9, 2025
Completion date
August 17, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post traumatic stress disorder, ptsd